Each Altus mandate is assembled from a single relationship officer and a private team drawn from one or more of our six practice groups. No practice operates on commission; all share a single P&L.
For categories where no public benchmark exists — specialised biologics, second-tier metals, sanction-adjacent inputs — our Strategic Sourcing officers compress price discovery from quarters to weeks.
We maintain proprietary intelligence on 18,400 qualified suppliers across 64 jurisdictions, refreshed continuously by ten regional desks.
We secure constrained, sometimes politically exposed medicines for public-health buyers under full cold-chain custody. Each shipment travels with a dedicated qualified person and our own digital chain-of-custody ledger.
Turbines, transformers, valves, refinery long-leads. We close nine-figure tickets in 14 weeks where OEM lead-times run sixty-plus. Our advantage is a permanent presence inside the world's three major OEM ecosystems and the secondary surplus market.
For multi-year capital builds — hospitals, ministries, airports, national grid expansions — we deliver a fully staffed procurement office, embedded in the client's PMO from FEED through commissioning. We arrive with our methodology, our systems, and our discipline. We depart leaving institutional muscle behind.
Mandates under end-user-certificate frameworks, including ITAR, EAR, EU dual-use and Wassenaar. Every counterparty is screened against five sanctions registers and our own four-continent due-diligence partners. We refuse mandates we cannot defend.
Quiet sourcing for private offices, sovereign-aligned foundations, and individuals operating under counsel. We act inside privileged channels and we leave no marketing footprint, ever — including on this site, which is the only outward face we maintain.